Combination therapy

• Health & Medicine

Non-Hodgkin lymphoma treatment gets an initial ‘no’ for NHS use in England

A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.  A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England. 

11 March 2020

• Health & Medicine

‘Chemotherapy-free’ treatment for lymphoma made available for NHS use in England

New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England. New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.

28 February 2020

• Health & Medicine

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

17 February 2020

• Health & Medicine

Two skin cancer treatments get the green light for NHS Scotland

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

12 February 2020

• Health & Medicine

Immunotherapy for triple negative breast cancer gets initial ‘no’ for NHS in England

An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England. An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.

3 October 2019

• Health & Medicine

Lung cancer immunotherapy combo added to Cancer Drugs Fund

Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England. Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.

8 August 2019

• Health & Medicine

Breast cancer drug combo gets initial ‘no’ for NHS in England

Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use. Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use.

10 April 2019

• Health & Medicine

Drug combination boosts kidney cancer survival in trials

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials. Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

19 February 2019

• Health & Medicine

Chemo combo could help pancreatic cancer patients live longer after surgery

A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery. A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery.

4 June 2018